Zno nanoparticles and rifampicin synergistically damage the membrane of mycobacteria
N Mistry, R Bandyopadhyaya… - ACS Applied Nano …, 2020 - ACS Publications
The emergence of drug resistance in tuberculosis requires alternative strategies to combat
the resistance. To this end, we have synthesized zinc oxide nanoparticles (ZnO NPs) of 11 …
the resistance. To this end, we have synthesized zinc oxide nanoparticles (ZnO NPs) of 11 …
The Anti-Mycobacterial Activity Of Ag, ZnO, And Ag- ZnO Nanoparticles Against MDR- And XDR-Mycobacterium tuberculosis
M Heidary, S Zaker Bostanabad, SM Amini… - Infection and Drug …, 2019 - Taylor & Francis
Background Nowadays, tuberculosis (TB) is one of the top ten leading causes of mortality
worldwide. The emergence of multidrug-resistant (MDR)–and extensively drug-resistant …
worldwide. The emergence of multidrug-resistant (MDR)–and extensively drug-resistant …
Escherichia coli Bacteria Develop Adaptive Resistance to Antibacterial ZnO Nanoparticles
Antibacterial agents based on nanoparticles (NPs) have many important applications, eg, for
the textile industry, surface disinfection, wound dressing, water treatment, and food …
the textile industry, surface disinfection, wound dressing, water treatment, and food …
Antibacterial Efficacy of ZnO/Bentonite (Clay) Nanocomposites against Multidrug-Resistant Escherichia coli
The emergence of multidrug-resistant (MDR) bacteria has spurred the exploration of
therapeutic nanomaterials such as ZnO nanoparticles. However, the inherent nonspecific …
therapeutic nanomaterials such as ZnO nanoparticles. However, the inherent nonspecific …
Zinc oxide nanoparticles conjugated with clinically-approved medicines as potential antibacterial molecules
At present, antibiotic resistance is one of the most pressing issues in healthcare globally.
The development of new medicine for clinical applications is significantly less than the …
The development of new medicine for clinical applications is significantly less than the …
Multimetallic Microparticles Increase the Potency of Rifampicin against Intracellular Mycobacterium tuberculosis
Mycobacterium tuberculosis (M. tb) has the extraordinary ability to adapt to the
administration of antibiotics through the development of resistance mechanisms. By rapidly …
administration of antibiotics through the development of resistance mechanisms. By rapidly …
An overview of zinc oxide nanoparticles produced by plant extracts for anti-tuberculosis treatments
Tuberculosis (TB), induced by Mycobacterium tuberculosis (MTB), is a fatal infectious
disease that kills millions of lives worldwide. The emergence of drug-resistant and multidrug …
disease that kills millions of lives worldwide. The emergence of drug-resistant and multidrug …
Antibacterial action and target mechanisms of zinc oxide nanoparticles against bacterial pathogens
CR Mendes, G Dilarri, CF Forsan, VMR Sapata… - Scientific reports, 2022 - nature.com
Abstract Zinc oxide nanoparticles (ZnO NPs) are one of the most widely used
nanoparticulate materials due to their antimicrobial properties, but their main mechanism of …
nanoparticulate materials due to their antimicrobial properties, but their main mechanism of …
Biogenic Zinc Oxide Nanoparticles: An Insight into the Advancements in Antimicrobial Resistance
A Sharma, K Akash, S Kumari… - ECS Journal of Solid …, 2024 - iopscience.iop.org
Multidrug resistance (MDR) is a significant global challenge requiring strategic solutions to
address bacterial infections. Recent advancements in nanotechnology, particularly in the …
address bacterial infections. Recent advancements in nanotechnology, particularly in the …
Selective antibacterial effects of mixed ZnMgO nanoparticles
Antibiotic resistance has impelled the research for new agents that can inhibit bacterial
growth without showing cytotoxic effects on humans and other species. We describe the …
growth without showing cytotoxic effects on humans and other species. We describe the …